JOHNNY HEDGES: Open Payments
NPI 1811606858 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 22 payments from 9 companies in 2025. Trend: 2023 $308 · 2024 $857 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| CVRx, Inc. | 1 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| PFIZER INC. | 2 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: LEQVIO, WAINUA, Barostim Neo System, ELIQUIS, JARDIANCE, LOKELMA, CAMZYOS, FUROSCIX.
Industry payments across TX — which companies pay providers there.
